Heather Barry, a 34-year-old mother from Massachusetts, was diagnosed with Stage III colon cancer in January 2024 after several months of seeking medical attention for worsening abdominal symptoms. Physicians initially attributed her condition to common postpartum issues and hemorrhoids following the birth of her third child in May 2023. Her diagnosis follows a trend noted by the American Cancer Society regarding an increase in colorectal cancer cases among younger adults.
Between September and December 2023, Barry consulted an obstetrician-gynecologist, a primary care physician, a colorectal surgeon, and a gastroenterologist. According to Barry, these providers variously recommended stool softeners, a high-fiber diet, hydrocortisone cream, and pelvic floor therapy, suggesting her symptoms were related to hormone imbalances or postpartum recovery. Barry reported losing 30 pounds and experiencing significant pain before a colonoscopy and endoscopy in early 2024 identified a five-centimeter tumor in her colon.
Dr. Ted Hong, director of gastrointestinal radiation oncology at Mass General Hospital, stated that Barry's experience is not unusual for younger patients. He noted that colorectal cancer in individuals her age is often not a primary consideration for many primary care physicians, frequently requiring patients to engage in self-advocacy to reach a diagnosis. Following the identification of the tumor, Barry underwent an aggressive treatment regimen including a colostomy, eight sessions of chemotherapy, six weeks of radiation, and surgical resection.
For the approximately 1.5 million people diagnosed with various cancers annually in the U.S., the impact involves intensive medical costs and lifestyle interruptions. Patients like Barry undergo months-long treatments—in this case, including a colostomy and eight bi-weekly chemotherapy sessions—that cause side effects such as hand dysfunction and cold sensitivity. Furthermore, these diagnoses create long-term medical requirements for families; Barry’s children, for example, will now be required to begin regular screenings at age 25, twenty years earlier than the general population recommendation.
The clinical response to this trend has already resulted in concrete changes to national health guidelines. The recommended age for initial colorectal cancer screenings for adults at average risk was lowered from 50 to 45. Individuals who do not meet these age criteria but exhibit symptoms may face diagnostic delays if providers do not consider colorectal cancer a possibility. Moving forward, Barry will remain under surveillance with follow-up visits every three months and annual colonoscopies for at least two to three years to monitor for recurrence.